Related Experiment Video

Updated: Jan 7, 2026

A Modified Co-Culture System for Understanding Granulosa-Theca Cell Interactions in the Bovine Ovary
07:03

A Modified Co-Culture System for Understanding Granulosa-Theca Cell Interactions in the Bovine Ovary

Published on: September 19, 2025

512

Combination Hormonal Drug Therapy Inhibits In Vitro Growth of Adult Ovarian Granulosa Tumor Cells

Rebekah M Summey1, Marissa Iden1, Shirng-Wern Tsaih1

  • 1Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.

Cancer Investigation
|December 26, 2025
PubMed

Insights

This study shows that combining anti-androgen and aromatase inhibitor drugs effectively suppresses adult-type granulosa cell tumor (AGCT) cell growth. Further clinical investigation of this anti-hormonal regimen for AGCT is warranted.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Adult-type granulosa cell tumors (AGCT) are rare ovarian cancers.
  • Effective targeted therapies for AGCT remain limited.

Purpose of the Study:

  • To investigate the in vitro efficacy and mechanism of action of an anti-hormonal drug combination for AGCT.
  • To evaluate the impact of anti-androgens and aromatase inhibitors on AGCT cell proliferation.

Main Methods:

  • Cell proliferation assays were used to determine IC50 values for bicalutamide, anastrozole, and leuprolide acetate alone and in combination.
  • RNA sequencing was performed on AGCT cells treated with anastrozole and darolutamide.

Main Results:

  • Bicalutamide and anastrozole demonstrated significant IC50 values (7.3 µM and 6.2 µM, respectively).
  • Combination therapy with an anti-androgen and aromatase inhibitor enhanced proliferation suppression.
  • RNA sequencing revealed downregulation of DNA synthesis and cell cycle pathways, with upregulation of MHC I activity and DNA damage response.

Conclusions:

  • An anti-hormonal drug combination shows promise for treating AGCT.
  • This regimen warrants further prospective clinical investigation.
Keywords:
Gene expressionOvarian cancerTreatment

More Related Videos

Bovine Ovarian Cortex Tissue Culture06:32

Bovine Ovarian Cortex Tissue Culture

Published on: January 14, 2021

5.3K
A Tissue Culture Model of Estrogen-producing Primary Bovine Granulosa Cells05:36

A Tissue Culture Model of Estrogen-producing Primary Bovine Granulosa Cells

Published on: September 6, 2018

9.7K

Related Concept Videos

Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.4K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.3K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.0K